Skip to main content

Month: April 2020

Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats

Basel, 08. April 2020Basilea Pharmaceutica AG (SIX: BSLN) gab bekannt, dass die Aktionärinnen und Aktionäre an der heutigen ordentlichen Generalversammlung (GV) für das Geschäftsjahr 2019 allen vom Verwaltungsrat vorgeschlagenen Anträgen zugestimmt haben.Entsprechend der COVID-19-Verordnung 2 des Bundesrats war eine physische Teilnahme von Aktionärinnen und Aktionären an der GV weder möglich noch erlaubt. Bereits am 20. März hatte Basilea ihren Aktionärinnen und Aktionären empfohlen, ihre Stimmrechte durch die unabhängige Stimmrechtsvertreterin ausüben zu lassen. An der GV repräsentierte die unabhängige Stimmrechtsvertreterin 26.2 Prozent der Stimmrechte. Aktuell sind 58.8 Prozent der ausstehenden Aktien im Aktienregister von Basilea eingetragen.Domenico Scala, Präsident des Verwaltungsrats der Basilea sagte: „Wir danken unseren Aktionärinnen...

Continue reading

Euro Manganese annonce la clôture de la première tranche du placement privé et l’octroi d’options d’achat

CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNISVANCOUVER, Colombie-Britannique, 08 avr. 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V / ASX : EMN) (la « Société » ou « EMN ») est ravie d’annoncer la clôture du placement privé sans courtage (l’« Offre ») annoncé le 24 mars 2020, ainsi que l’octroi d’options d’achat. Clôture de la première tranche du placement privéLa première tranche comprenait 4 477 170 actions ordinaires (les « Actions ») et 227 273 titres de dépôt CHESS (les « CDI », chaque CDI représentant une Action), au prix de 0,11 dollar canadien par Action et 0,13 dollar australien par CDI, pour un produit brut cumulé d’environ 517 489 dollars canadiens.La deuxième tranche de l’Offre (la « Tranche...

Continue reading

Euro Manganese kündigt den Abschluss der ersten Tranche der Privatplatzierung und die Gewährung von Aktienoptionen an

NICHT ZUR VERTEILUNG AN NACHRICHTENAGENTUREN DER VEREINIGTEN STAATEN ODER ZUR VERBREITUNG IN DEN VEREINIGTEN STAATENVANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) —  Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) gibt hoch erfreut den Abschluss der am 24. März 2020 angekündigten ersten Tranche der nicht vermittelten Privatplatzierung (das „Angebot“) sowie eine Gewährung von Aktienoptionen bekannt. Abschluss der ersten Tranche der PrivatplatzierungDie erste Tranche umfasste 4.477.170 Stammaktien („Aktien“) und 227.273 CHESS Depositary Interests („CDIs“, wobei jedes CDI einer Aktie entspricht) zu einem Preis von jeweils 0,11 CAD pro Aktie und 0,13 AUD pro CDI mit einem Gesamtbruttoerlös von 517.489 CAD.Die zweite Tranche des Angebots (die „Tranche für verbundene Parteien“), die aus Zeichnungen durch...

Continue reading

Philly Shipyard Wins Major Training Ships Contract

Philadelphia, PA (April 8, 2020) – Philly Shipyard, Inc., the sole operating subsidiary of Philly Shipyard ASA (Oslo: PHLY), has been awarded a contract for the construction of up to five (5) National Security Multi-Mission Vessels (NSMV) from TOTE Services, LLC (TOTE), an industry leader in ship management, marine operations and vessel services. TOTE was selected by the U.S. Department of Transportation’s Maritime Administration (MARAD) as the vessel construction manager for the NSMV program in May 2019. TOTE placed an initial order with Philly Shipyard for the first two vessels (NSMVs 1 and 2), with deliveries in Spring and Winter 2023, and retains options for the next three vessels (NSMVs 3, 4 and 5).The initial award is valued at approximately USD 630 million and supports non-recurring engineering and detail design of the NSMV class...

Continue reading

Philips and the U.S. government collaborate in ventilator production ramp up to combat COVID-19 pandemic

April 8, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the U.S. Government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing sites in the U.S. Philips plans to double the production by May 2020  and achieve a four-fold increase by the third quarter of 2020 for supply to the U.S. and global markets. Such ventilators are critical for the treatment of patients with the new coronavirus disease (COVID-19). Philips will invest several tens of millions in its ventilator manufacturing sites in the U.S.“We are actively collaborating with the U.S. government to help save lives in the U.S. and across the globe,” said Frans van Houten, CEO of Royal Philips. “There is an unprecedented global demand for medical equipment...

Continue reading

FIRAN TECHNOLOGY GROUP CORPORATION (“FTG” OR “THE CORPORATION”) ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) today announced financial results for the first quarter 2020.Ended Q1 2020 with over $51M in total backlog.  Of this, over $30M is due in Q2 2020Generated $3.5M in cash in Q1 and ended the quarter with $5.2M in net cash on the balance sheetIncluded in the Q1 2020 net loss was a non-cash expense to reduce the intangible asset from an acquisition in 2016 due to increased market uncertainty going forwardFirst Quarter Results: (three months ended Feb 28, 2020 compared with three months ended Mar 1, 2019)(1)     Operating Earnings is not a measure recognized under International Financial Reporting Standards (“IFRS”).  Management believes that this measure is important to many of the Corporation’s shareholders, creditors and other stakeholders. The...

Continue reading

OptimizeRx Recognized as One of The Americas’ Fastest-Growing Companies by The Financial Times

ROCHESTER, Mich., April 08, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has received the ranking of #282 by the Financial Times’ 2020 list of The Americas’ 500 Fastest-Growing Companies.The FT Americas list was compiled in coordination with the leading research firm Statista, which ranked the top 500 companies in North and South America by their compounded annual revenue growth rate between 2015 and 2018. OptimizeRx’s growth rate exceeded 43% during the period.“We’re honored to be recognized by the Financial Times, one of the world’s most widely read and respected business publications,” said William Febbo, CEO of OptimizeRx. “Our strong ranking reflects the tremendous efforts and dedication of our team which...

Continue reading

Ahold Delhaize shareholders adopt 2019 financial statements and approve all agenda points

Amsterdam, the Netherlands, April 8, 2020 – Ahold Delhaize today held its Annual General Meeting (AGM). Unlike past general meetings, due to the COVID-19 health risk, Ahold Delhaize had urged shareholders not to attend this AGM in-person. Instead shareholders were asked to vote and submit questions in advance of the meeting.  The voting rights of approximately 655 million shares were represented and exercised through electronic or written proxy during or in advance of the meeting. The meeting was webcast live via the Ahold Delhaize corporate website.   Shareholders adopted Ahold Delhaize’s 2019 financial statements and agreed to the proposed 2019 annual dividend of €0.76 per common share, to be paid on April 23, 2020.  Shareholders adopted all other proposals on the agenda, including the appointment of Natalie Knight as Chief Financial...

Continue reading

FLAUREA Chemicals, filiale d’AUREA, se mobilise pour accompagner ses clients

FLAUREA Chemicals, filiale d’AUREA se mobilise pour accompagner ses clientsAUREA (Code ISIN : FR0000039232, Code Mnémo : AURE), l’un des premiers acteurs industriels européens dans la régénération des déchets, se mobilise pour accompagner ses clients qui se doivent d’assurer un plan de continuité de services en raison de la pandémie Covid-19.Ainsi, FLAUREA Chemicals, filiale du Groupe AUREA, active dans la chimie des métaux non ferreux pour la fabrication de produits de niche à destination des industries du monde entier, adapte son organisation en mettant en place un plan de continuité d’activité afin d’approvisionner ses clients et leur permettre de maintenir leurs activités essentielles au service de l’intérêt général.En effet, FLAUREA Chemicals au travers de son activité de chlorure de zinc est un acteur stratégique et indispensable...

Continue reading

COVID-19: Bonduelle and its partners mobilize to weather today’s hardships and anticipate tomorrow’s challenges

BONDUELLEA French SCA (Limited Partnership by Shares) with a capital of 56,942,095 EurosHead Office: La Woestyne 59173 Renescure, FranceRegistration number: Dunkerque B 447 250 044COVID-19: Bonduelle and its partners mobilize to weather today’s hardships and anticipate tomorrow’s challengesIn a context of great uncertainty, the group suspends its 2019-2020 financial objectivesThe Bonduelle Group has always assumed its responsibilities with regard to its place in the agri-food sector chain. Canned foods, frozen vegetables and fresh vegetables – essential elements of a healthy and sustainable diet that are at the heart of the population’s daily needs.Today, this responsibility is more than ever a driving force for all the Bonduelle teams who, at the group’s 56 production and packaging sites, are working hard to maintain the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.